Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Population Genomics, |
RCV003991418 | SCV004808960 | likely pathogenic | Rett syndrome | 2024-01-19 | criteria provided, single submitter | curation | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as likely pathogenic. At least the following criteria are met: Occurs in the well-characterized Methyl-DNA binding (MDB) functional domain of MECP2 (PM1). Another missense variant in the same codon has been classified as pathogenic for Rett syndrome by the ClinGen Rett and Angelman-like Disorders Expert Panel (PM5, ClinVar ID 143579). Computational prediction analysis tools suggests a deleterious impact (REVEL score > 0.75) (PP3). This variant is absent from gnomAD (PM2_Supporting). |
Gene |
RCV004719405 | SCV005326277 | pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate that this variant damages the normal protein function (PMID: 28785396); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28785396, 12843318, 21831886) |